Publication:
Changes in 18F-FDG-PET/CT tumor metabolism and prediction of pathologic complete response rates after neoadjuvant chemotherapy in hormone-positive breast cancer.

dc.contributor.authorsKaya, Serap; Aktas, Bilge; Simsek, Eda Tanrikulu; Ozturk, Mehmet Akif; Dede, Fuat; Kaya, Handan; Ugurlu, Umit Mustafa; Ozgen, Zerrin; Koca, Sinan; Halil, Suleyman; Hasanov, Rahib; Alan, Ozkan; Babacan, Nalan; Dane, Faysal; Gumus, Mahmut; Yumuk, Fulden Perran
dc.date.accessioned2022-03-12T16:16:38Z
dc.date.accessioned2026-01-11T19:17:20Z
dc.date.available2022-03-12T16:16:38Z
dc.date.issued2016
dc.identifier.doi10.1200/JCO.2016.34.15_suppl.e12088
dc.identifier.eissn1527-7755
dc.identifier.issn0732-183X
dc.identifier.urihttps://hdl.handle.net/11424/225794
dc.identifier.wosWOS:000404665401115
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleChanges in 18F-FDG-PET/CT tumor metabolism and prediction of pathologic complete response rates after neoadjuvant chemotherapy in hormone-positive breast cancer.
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.issue15
oaire.citation.titleJOURNAL OF CLINICAL ONCOLOGY
oaire.citation.volume34

Files